Tedros added that the agency had triggered the process for emergency use listing of the two mpox vaccines – Bavarian Nordic’s Jynneos and KM Biologics LC16 – to help accelerate access to the shots. Congo authorities had approved the use of both the vaccines in June.
News
WHO to convene emergency committee to assess international risk from mpox outbreak
August 9, 2024Tedros added that the agency had triggered the process for emergency use listing of the two mpox vaccines – Bavarian Nordic’s Jynneos and KM Biologics LC16 – to help accelerate access to the shots. Congo authorities had approved the use of both the vaccines in June.